| |
| |
|
| Insider
Information: |
Lavino Francesco Maria |
| Relationship: |
Chief Commercial Officer |
| City: |
King Of Prussia |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
185,393 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$73,008 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
185,393 |
|
|
| Total
Value |
$73,008 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nabriva Therapeutics AG |
NBRV |
Chief Commercial Officer |
2020-09-30 |
185,393 |
2017-11-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2020-09-30 |
4 |
D |
$0.53 |
$195 |
D/D |
(366) |
185,393 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2020-08-31 |
4 |
D |
$0.62 |
$227 |
D/D |
(366) |
185,759 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2020-08-20 |
4 |
D |
$0.65 |
$2,434 |
D/D |
(3,759) |
186,125 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2020-08-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,250 |
189,884 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2020-07-31 |
4 |
D |
$0.76 |
$278 |
D/D |
(366) |
178,634 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2020-06-30 |
4 |
D |
$0.67 |
$247 |
D/D |
(366) |
179,000 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2020-05-31 |
4 |
D |
$1.14 |
$417 |
D/D |
(366) |
179,366 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2020-04-30 |
4 |
D |
$0.55 |
$201 |
D/D |
(366) |
179,732 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2020-03-31 |
4 |
D |
$0.58 |
$210 |
D/D |
(366) |
180,098 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2020-02-28 |
4 |
D |
$1.35 |
$494 |
D/D |
(366) |
180,464 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2020-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
180,830 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2020-01-31 |
4 |
D |
$1.35 |
$5,254 |
D/D |
(3,892) |
75,830 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2019-08-22 |
4 |
B |
$2.04 |
$9,780 |
D/D |
4,800 |
15,972 |
2.74 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2019-08-21 |
4/A |
S |
$2.08 |
$7,898 |
D/D |
(3,797) |
11,172 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2019-08-21 |
4 |
D |
$2.08 |
$7,898 |
D/D |
(3,797) |
11,172 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2019-08-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,250 |
14,969 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2018-05-23 |
4 |
B |
$4.60 |
$9,936 |
D/D |
2,160 |
3,719 |
2.74 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Commercial Officer |
• – – |
2017-11-29 |
4 |
B |
$6.29 |
$9,869 |
D/D |
1,569 |
1,569 |
2.74 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
